A 1 Stock Price Today (NSE: AIL)
Fundamental Score
A 1 Share Price — Live NSE/BSE Price, Fundamentals & Analysis
A 1 share price today is ₹37.55, up +0.00% on NSE/BSE as of 1 August 2026. A 1 (AIL) is a Small-cap company in the Trading - Chemicals sector with a market capitalisation of ₹276.92 (Cr). The 52-week high for AIL share price is ₹61.00 and the 52-week low is ₹23.75. At a P/E ratio of 46.23x, AIL is currently trading above its industry average P/E of 34.69x. The company has a Return on Equity (ROE) of 11.55% and a debt-to-equity ratio of 0.77.
A 1 Share Price Chart — NSE/BSE Historical Performance
A 1 share price chart: 9.48% return over the past month. 52-week high ₹61.00, 52-week low ₹23.75.
A 1 — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹37.55 | ₹37.55 | ₹37.55 | ₹37.55 | 0.00 (Cr) | |
| ₹37.55 | ₹37.55 | ₹37.55 | ₹37.55 | 1.50K (Cr) | |
| ₹39.50 | ₹39.50 | ₹39.50 | ₹39.50 | 0.00 (Cr) | |
| ₹39.50 | ₹39.50 | ₹39.50 | ₹39.50 | 0.00 (Cr) | |
| ₹39.50 | ₹39.50 | ₹39.50 | ₹39.50 | 1.50K (Cr) | |
| ₹41.55 | ₹41.55 | ₹41.55 | ₹41.55 | 4.50K (Cr) | |
| ₹43.50 | ₹43.70 | ₹43.50 | ₹43.70 | 7.50K (Cr) | |
| ₹41.50 | ₹41.65 | ₹41.50 | ₹41.65 | 10.50K (Cr) | |
| ₹39.75 | ₹39.75 | ₹39.75 | ₹39.75 | 10.50K (Cr) | |
| ₹37.90 | ₹37.90 | ₹37.90 | ₹37.90 | 3.00K (Cr) |
A 1 — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹34.30 | ₹43.70 | ₹32.30 | ₹37.55 | +9.48% | |
| ₹40.00 | ₹40.00 | ₹34.30 | ₹34.30 | -14.25% | |
| ₹41.40 | ₹44.50 | ₹41.40 | ₹42.00 | +1.45% | |
| ₹34.20 | ₹41.40 | ₹29.70 | ₹41.40 | +21.05% | |
| ₹36.55 | ₹43.90 | ₹35.10 | ₹36.00 | -1.50% | |
| ₹24.90 | ₹36.55 | ₹23.75 | ₹36.55 | +46.79% | |
| ₹39.00 | ₹39.00 | ₹26.20 | ₹26.20 | -32.82% | |
| ₹43.70 | ₹43.70 | ₹39.60 | ₹40.00 | -8.47% | |
| ₹40.60 | ₹47.50 | ₹40.60 | ₹43.70 | +7.64% | |
| ₹39.00 | ₹42.20 | ₹36.70 | ₹40.60 | +4.10% | |
| ₹42.95 | ₹45.00 | ₹38.85 | ₹40.00 | -6.87% | |
| ₹58.80 | ₹61.00 | ₹39.85 | ₹45.20 | -23.13% |
AI Research Briefing
Powered by Gemini · 2026-08-01
Unbacked micro-cap trap where a 419% quarter profit surge fails to compensate for a negative ₹11.1 Cr 5-year free cash flow.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Board meeting scheduled on July 28, 2026 to consider Q1 FY27 financial results. No major order wins, client acquisitions, or material operational catalysts found after live search.
CORE STORY (THE REAL GAME)
Micro-cap chemical trading entity attempting to re-rate on headline profit growth (+419.05% YoY in latest quarter), while underlying operations suffer severe cash burn with negative 5-year free cash flow of -₹11.1 Cr.
- No major catalysts found after live search; Q1 FY27 board meeting scheduled July 28, 2026.
- Institutional capitulation with FII holding dropping -0.43% and DII sitting at 0.0%.
- Severe momentum collapse with a 6-month decline of -81.19%.
- Sustained Q1 FY27 earnings beat exceeding 400% YoY net profit growth.
- Potential material contract wins in specialized chemical distribution.
- Structural margin expansion above 5% operating profit threshold.
- Extreme SME/Micro-cap liquidity risk with market cap of ₹276.92 Cr.
- Negative 5-year cumulative Free Cash Flow of -₹11.1 Cr.
- Razor-thin 5-year average Operating Profit Margin at 2.64%.
Institutional money is exiting: FII down -0.43% to 6.28%, DII down -0.09% to 0.00%, while Promoter stake remains flat at 70.03%.
Indian chemical export sector targets $38B in 2026, but pure-play trading intermediaries face severe margin pressure.
No major catalysts or contract wins found after live search.
No — 5-year cumulative Free Cash Flow is negative at -₹11.1 Cr despite accounting profit.
High probability of further valuation derating due to poor cash conversion. Rebound requires sustainable margin expansion and positive free cash flow generation.
Primary Thesis Risk
Persistent cash burn combined with micro-cap illiquidity accelerating capital erosion.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
A 1 Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
A 1 Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AIL across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Robust Profit Growth (419.05%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (32.52%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (18.76% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (17.63% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (17.63% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (5.86x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (70.03%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Margin Pressure Concerns (2.64%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 46.23x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-11.10 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 6.28%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
A 1 vs Trading - Chemicals Peers
Peer Comparison - Trading - Chemicals
Compare A 1 with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
A 1A 1...Selected✓ AIL • 542012 | 54.6/100 | ₹37.55₹38 | ₹276.92₹276.92 | 46.23Average 46.2 Average | 11.55%Average 11.55% Average | 11.66%Average 11.66% Average | 0.77Good 0.8 Good | 17.63%Excellent 17.63% Excellent | 18.76%Excellent 18.76% Excellent | 0.62% |
Uniphos Enterprises LtdUniphos Enterpr... UNIENTER • 500429 | 33.3/100 | ₹94.92₹95 | ₹748.08₹748.08 | 36.12Average 36.1 Average | 0.80%Poor 0.80% Poor | 0.80%Poor 0.80% Poor | 0.00Excellent 0.0 Excellent | -2.80%Poor -2.80% Poor | 107.59%Excellent 107.59% Excellent | 3.25% |
Vinyl Chemicals India LtdVinyl Chemicals... VINYLINDIA • 524129 | 38.6/100 | ₹241.80₹242 | ₹458.99₹458.99 | 36.46Average 36.5 Average | 9.80%Poor 9.80% Poor | 14.86%Average 14.86% Average | 0.00Excellent 0.0 Excellent | 2.24%Average 2.24% Average | 10.05%Good 10.05% Good | 2.78% |
Evexia Lifecare LtdEvexia Lifecare... EVEXIA • 524444 | 21.4/100 | ₹1.50₹2 | ₹300.38₹300.38 | 185.42Average 185.4 Average | — — | — — | 2.16Poor 2.2 Poor | 4.34%Average 4.34% Average | 0.68%Average 0.68% Average | 0.00% |
16.9/100 | ₹30.45₹30 | ₹298.03₹298.03 | 34.69Average 34.7 Average | 17.90%Good 17.90% Good | 22.12%Excellent 22.12% Excellent | 0.12Excellent 0.1 Excellent | — — | — — | 0.00% | |
Shiv Texchem LtdShiv Texchem Lt... SHIVTEXCHEM • 544272 | 56/100 | ₹110.75₹111 | ₹281.20₹281.20 | 3.61Average 3.6 Average | 20.93%Excellent 20.93% Excellent | 15.30%Good 15.30% Good | 1.71Average 1.7 Average | 55.21%Excellent 55.21% Excellent | 52.73%Excellent 52.73% Excellent | 0.00% |
63.1/100 | ₹37.44₹37 | ₹252.97₹252.97 | 18.75Average 18.8 Average | 11.61%Average 11.61% Average | 14.01%Average 14.01% Average | 0.21Excellent 0.2 Excellent | 12.07%Good 12.07% Good | 21.22%Excellent 21.22% Excellent | 0.13% | |
Mysore Petro Chemicals LtdMysore Petro Ch... MYSORPETRO • 506734 | 49.4/100 | ₹99.90₹100 | ₹64.91₹64.91 | 80.13Average 80.1 Average | 0.36%Poor 0.36% Poor | 0.38%Poor 0.38% Poor | 0.00Excellent 0.0 Excellent | 17.92%Excellent 17.92% Excellent | 17.98%Excellent 17.98% Excellent | 2.03% |
Yash Chemex LtdYash Chemex Ltd... YASHCHEM • 539939 | 37.4/100 | ₹53.87₹54 | ₹53.94₹53.94 | 26.70Average 26.7 Average | 5.13%Poor 5.13% Poor | 6.44%Poor 6.44% Poor | 0.34Excellent 0.3 Excellent | 1.23%Average 1.23% Average | 20.59%Excellent 20.59% Excellent | 0.00% |
Laffans Petrochemicals LtdLaffans Petroch... LAFFANSQ • 524522 | 22.1/100 | ₹29.22₹29 | ₹20.99₹20.99 | 51.20Average 51.2 Average | 0.64%Poor 0.64% Poor | 0.40%Poor 0.40% Poor | 0.01Excellent 0.0 Excellent | -29.53%Poor -29.53% Poor | -21.71%Poor -21.71% Poor | 0.00% |
Citichem India LtdCitichem India ... CITICHEM • 544324 | 32.4/100 | ₹15.50₹16 | ₹11.15₹11.15 | 11.15Average 11.2 Average | 4.85%Poor 4.85% Poor | 7.18%Poor 7.18% Poor | 0.37Excellent 0.4 Excellent | 35.37%Excellent 35.37% Excellent | -39.35%Poor -39.35% Poor | 0.00% |
Top Trading - Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Uniphos Enterprises Ltd share price748.08 Cr
- Vinyl Chemicals India Ltd share price458.99 Cr
- Evexia Lifecare Ltd share price300.38 Cr
- Dhariwal Corporation Ltd share price298.03 Cr
- Shiv Texchem Ltd share price281.20 Cr
A 1 Quarterly Performance
Latest quarterly metrics for AIL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
32.52%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
419.05%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
18.76%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
17.63%
Compounded annual net profit growth over 5 years
A 1 Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AIL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
A 1 Financial Statements
Annual income statement, balance sheet and cash flow for A 1 (AIL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for A 1
About AIL (A 1)
A 1 (AIL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Trading - Chemicals sector with a current market capi...talisation of ₹276.92 (Cr). A 1 has delivered a Return on Equity (ROE) of 11.55% and a ROCE of 11.66%. The debt-to-equity ratio stands at 0.77, reflecting the company's capital structure. Investors tracking AIL share price can monitor key metrics including P/E ratio, promoter holding of 70.03%, and quarterly earnings growth.
Company Details
Latest News
AIL Share Price: Frequently Asked Questions
What is the current share price of A 1?
A 1 (AIL) trades at ₹37.55 on NSE and BSE. Market cap ₹276.92 (Cr). Educational data only.
What is the P/E ratio of A 1?
A 1 has a P/E of 46.23x vs industry average 34.69x.
What is the Bull Run score for A 1?
A 1 has a Bull Run score of 54.6/100 based on 25+ financial parameters.
Does A 1 pay dividends?
A 1 has a dividend yield of 0.62%. Past dividends don't guarantee future payments.
What is the ROE of A 1?
A 1 has ROE of 11.55%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of A 1?
A 1 has debt-to-equity of 0.77.
Is A 1 a good investment?
Bull Run gives A 1 a score of 54.6/100. This is not investment advice — consult a SEBI-registered advisor.